StockNews.com began coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) in a research note published on Saturday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance NASDAQ:GLMD opened at $3.60 on Friday. Galmed Pharmaceuticals has a 12-month low of $3.43 and a 12-month high of $14.18. […]
Equities research analysts at StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) in a note issued to investors on Saturday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance Shares of Galmed Pharmaceuticals stock opened at $3.60 on Friday. The business has a 50 day […]
Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) issued its earnings results on Thursday. The biopharmaceutical company reported ($1.09) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.50) by $0.41, Zacks reports. Galmed Pharmaceuticals Price Performance Shares of GLMD traded up $0.11 during mid-day trading on Friday, reaching $4.74. The company had a trading […]
Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) posted its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.09) earnings per share for the quarter, topping the consensus estimate of ($1.50) by $0.41, Zacks reports. Galmed Pharmaceuticals Price Performance Shares of NASDAQ:GLMD traded up $0.11 on Friday, hitting $4.74. The company’s stock had a trading volume […]
Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) issued its earnings results on Thursday. The biopharmaceutical company reported ($1.09) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.50) by $0.41, Zacks reports. Galmed Pharmaceuticals Price Performance Shares of GLMD traded up $0.11 during mid-day trading on Friday, reaching $4.74. The company had a trading […]